Integrative analysis of gut microbiota, metabolome, and systemic immunity reveals interconnected signatures in AD
AD is a complex neurodegenerative disorder and an escalating global health burden. While amyloid and tau pathology are well described, the peripheral processes connecting gut microbial imbalance, systemic metabolic disruption, and immune activation remain incompletely understood, and clinically useful noninvasive biomarkers are still limited.